Selective targeting of M‐type potassium Kv7.4 channels demonstrates their key role in the regulation of dopaminergic neuronal excitability and depression‐like behaviour

The mesolimbic dopamine system originating in the ventral tegmental area (VTA) is involved in the development of depression, and firing patterns of VTA dopaminergic neurons are key determinants in this process. Here, we describe a crucial role for the M‐type Kv7.4 channels in modulating excitability of VTA dopaminergic neurons and in the development of depressive behaviour in mice.

[1]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes , 2015, British journal of pharmacology.

[2]  D. Brown,et al.  Neural KCNQ (Kv7) channels , 2009, British journal of pharmacology.

[3]  J. Bolam,et al.  Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli , 2004, Science.

[4]  N. Tsuchimori,et al.  Activation of peripheral KCNQ channels attenuates inflammatory pain , 2014, Molecular pain.

[5]  Ming-Hu Han,et al.  Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure , 2016, Neuropsychopharmacology.

[6]  Aaron S. Andalman,et al.  Dopamine neurons modulate neural encoding and expression of depression-related behaviour , 2012, Nature.

[7]  W. Schultz Multiple dopamine functions at different time courses. , 2007, Annual review of neuroscience.

[8]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..

[9]  T. Jentsch Neuronal KCNQ potassium channels:physislogy and role in disease , 2000, Nature Reviews Neuroscience.

[10]  A. Zangen,et al.  Dissociation between Rewarding and Psychomotor Effects of Opiates: Differential Roles for Glutamate Receptors within Anterior and Posterior Portions of the Ventral Tegmental Area , 2008, The Journal of Neuroscience.

[11]  B S Brown,et al.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.

[12]  Jochen Roeper,et al.  Ih Channels Contribute to the Different Functional Properties of Identified Dopaminergic Subpopulations in the Midbrain , 2002, The Journal of Neuroscience.

[13]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[14]  T. Kosten,et al.  Acute stress diminishes M-current contributing to elevated activity of hypothalamic-pituitary-adrenal axis , 2017, Neuropharmacology.

[15]  Ming-Hu Han,et al.  KCNQ channel openers reverse depressive symptoms via an active resilience mechanism , 2016, Nature Communications.

[16]  A. Gershon,et al.  Dopamine D2-Like Receptors and the Antidepressant Response , 2007, Biological Psychiatry.

[17]  D. Overstreet,et al.  The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing , 2013, Pharmacological Reviews.

[18]  Vincent Seutin,et al.  The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  Stephen R. Williams,et al.  Errors in the measurement of voltage-activated ion channels in cell-attached patch-clamp recordings , 2011, Nature communications.

[20]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[21]  J. Bolam,et al.  Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat , 2008, Neuroscience.

[22]  M. Wong,et al.  Research and treatment approaches to depression , 2001, Nature Reviews Neuroscience.

[23]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Ligand‐gated ion channels , 2015, British journal of pharmacology.

[24]  S. B. Appel,et al.  Characterization of M-current in ventral tegmental area dopamine neurons. , 2006, Journal of neurophysiology.

[25]  Manoj Kumar,et al.  Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators , 2016, Molecular Pharmacology.

[26]  D. A. Brown,et al.  Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug Retigabine , 2001, The Journal of Neuroscience.

[27]  C. Heurteaux,et al.  Retroinverso analogs of spadin display increased antidepressant effects , 2014, Psychopharmacology.

[28]  R. Leuwer,et al.  Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness , 2006, The EMBO journal.

[29]  A. Grace,et al.  Regulation of firing of dopaminergic neurons and control of goal-directed behaviors , 2007, Trends in Neurosciences.

[30]  K. Deisseroth,et al.  Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning , 2009, Science.

[31]  Philippe Faure,et al.  Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors , 2006, Neuron.

[32]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels , 2015, British journal of pharmacology.

[33]  G. Debonnel,et al.  Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype , 2006, Nature Neuroscience.

[34]  M. Trudeau,et al.  Handbook of ion channels , 2015 .

[35]  Paul A Insel,et al.  Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.

[36]  C. Nemeroff,et al.  The role of dopamine in the pathophysiology of depression. , 2007, Archives of general psychiatry.

[37]  Yuan-yuan Zhang,et al.  Selective activation of vascular Kv7.4/Kv7.5 K+ channels by fasudil contributes to its vasorelaxant effect , 2016, British journal of pharmacology.

[38]  C. Leonard,et al.  Direct and Indirect Excitation of Laterodorsal Tegmental Neurons by Hypocretin/Orexin Peptides: Implications for Wakefulness and Narcolepsy , 2002, The Journal of Neuroscience.

[39]  K. Deisseroth,et al.  Rapid regulation of depression-related behaviors by control of midbrain dopamine neurons , 2012, Nature.

[40]  Vincent Seutin,et al.  Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS , 2008, The Journal of physiology.

[41]  Kelly R. Tan,et al.  Methamphetamine-Evoked Depression of GABAB Receptor Signaling in GABA Neurons of the VTA , 2012, Neuron.

[42]  E. Chevet,et al.  Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design , 2010, PLoS biology.

[43]  Ming-Hu Han,et al.  The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context , 2014, Neuroscience.

[44]  C. Lüscher,et al.  Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons via Calcium-Impermeable NMDARs , 2016, The Journal of Neuroscience.

[45]  C. Heurteaux,et al.  Targeting two‐pore domain K+ channels TREK‐1 and TASK‐3 for the treatment of depression: a new therapeutic concept , 2015, British journal of pharmacology.

[46]  Maxime Bonjean,et al.  M-type channels selectively control bursting in rat dopaminergic neurons , 2010, The European journal of neuroscience.

[47]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[48]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[49]  P. Slesinger,et al.  Sorting Nexin 27 Regulation of G Protein-Gated Inwardly Rectifying K+ Channels Attenuates In Vivo Cocaine Response , 2014, Neuron.

[50]  R. Neve,et al.  Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience , 2014, Science.

[51]  John C McGrath,et al.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.

[52]  E. Nestler,et al.  Mesolimbic Dopamine Neurons in the Brain Reward Circuit Mediate Susceptibility to Social Defeat and Antidepressant Action , 2010, The Journal of Neuroscience.